Announcements, news, events, and other publications produced by our office.

The Harvard University Office of Technology Development (OTD) provides a one-stop shop to advance the development of groundbreaking discoveries by fostering strategic collaborations with industry through licensing, sponsored research and new venture agreements.

Impact

Turning today's discoveries into tomorrow's transformational technologies.

By serving as a catalyst bridging the laboratory to industry, OTD ensures that promising new technologies are developed into products and services that benefit society and transform the world.

Leadership

Leading the way in discovery and application.

Harvard is a recognized world leader in discovery and innovation. Leadership means the determination to see that new technologies developed at Harvard reach their full potential and push the boundaries of the new scientific and industrial frontier.

Experience

At OTD, experience is a competitive advantage.

OTD's high performance team provides a solid foundation in science, business development, intellectual property and contract law that enables it to design creative "win-win" solutions that translate into enduring, fruitful relationships. When industry turns to OTD, it will find an agile, fast-paced group of professionals fully equipped to find creative solutions and make the deal-making process as efficient and effective as possible.

Partnership

The power of collaborative partnering.

Partnership is a vital pillar, a linchpin of OTD's business model. We have the focus, commitment and expertise to forge creative and productive partnerships. OTD is dedicated to fostering win/win relationships between faculty and industry, investors and entrepreneurs, relationships that will provide mutual and long-lasting benefit.

Blavatnik Biomedical Accelerator

Propelling promising Harvard life science innovations to partnership

To positively impact society, biomedical technology breakthroughs must first make the leap from the research lab to the commercial sphere. The Blavatnik Biomedical Accelerator at Harvard University is uniquely structured to bridge that gap, helping propel groundbreaking innovations toward next-generation products.

Media Center

Productivity Highlights

U.S. Patents Granted to the Faculty of Harvard University: 2006

United States Patents granted to members of the Faculty of Harvard University are compiled by fiscal year (July 1 - June 30). Select a link to view the list of patents awarded during that fiscal year. Note that space constraints do not permit listing all inventors on each patent. No slight is intended by omission of their names.

 

 

2006

Faculty Member

Faculty

Patent

Title
Gordon, Roy FAS 6,994,800 Liquid Precursor for Formation of Materials Containing Alkali Metals 
Gygi, Steven P. HMS 6,989,129 Automated Capillary Liquid Chromatography Small Volume Analysis System
Halperin, Jose A. HMS 6,992,079 Substituted 11-Phenyl Dibenzazepine Compounds Useful for the Treatment or Prevention of Diseases Characterized by Abnormal Cell Proliferation
Halperin, Jose A. HMS 7,049,082 Methods, Products, and Treatments for Diabetes
Hotamisligil, Gokhan S. HSPH 7,056,662 A Method of Diagnosing a Risk of Developing Insulin Resistance
Kirschner, Marc W. HMS 7,011,946 In Vivo Assay for Identification of Anti-Microbial Agents
Lieber, Charles M. FAS 6,963,077 Sublithographic Nanoscale Interfaces
Liu, Jun FAS 6,920,398 Haplotype Determination
MacBeath, Gavin FAS 7,063,979 Interface Betwen Substrates Having Microarrays and Microtiter Plates
Madras, Bertha HMS 7,026,516 Compounds with High Monoamine Transporter Affinity
Mazur, Eric FAS 7,057,256 Silicon-based Visible and Near-Infrared Optoelectric Devices
McKeon, Frank D. HMS 6,946,256 Cell Regulatory Genes, Encoded Products, and Uses Related Thereto
McKeon, Frank D. HMS 7,030,227 Cell Regulatory Genes, Encoded Products, and Uses Related Thereto
Melton, Douglas FAS 6,984,623 V-1 Composition
Melton, Douglas FAS 7,034,114 Signalin Family of TGFbeta Signal Transduction Proteins and Uses Related Thereto
Mitzenmacher, Michael D. FAS 6,920,477 Compressed Bloom Filter
Myrick, Kyl V. FAS 6,929,914 Method for Accelerated Genome Walking and DNA Fingerprinting
Schreiber, Stuart L. FAS 6,972,193 Regulated Transcription Of Targeted Gene And Other Biological Events
Schreiber, Stuart L. FAS 6,982,082 Gene Therapy by Cell-Specific Targeting
Schreiber, Stuart L. FAS 6,984,635 Novel Dimerizing Agents, Their Production and Use
Shair, Matthew D. FAS 7,045,360 Method for Analysis of Reaction Products
Strominger, Jack L. FAS 6,930,168 Therapeutic Peptides for Demyelinating Conditions
Tabin, Clifford J. HMS 7,060,450 Screening Assays for Agonists and Antagonists of the Hedgehog Signaling Pathway 
Verdine, Gregory L. FAS 6,987,180 Uridine Analogs and Techniques for Making and Using
Westwood, Nicholas J. HMS 7,067,315 Identification of Anti-Protozoal Agents
Whitesides, George M. FAS 7,007,370 Self-Assembled Electrical Networks
Whitesides, George M. FAS 7,014,799 Hierarchically Ordered Porous Oxides
Whitesides, George M. FAS 7,057,832 Microlens for Projection Lithography and Method of Preparation
Whitesides, George M. FAS 7,067,306 Adhering Cells to Cytophilic Islands Separated by Cytophobic Regions to Form Patterns and Manipulate Cells